Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACTHAR Therapy for Central Nervous System Sarcoidosis

NCT02920710 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02920710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02920710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACTHAR Therapy for Central Nervous System Sarcoidosis
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
February 1, 2019
Completion date
November 2, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis